Roseann B. Termini, B.S., Ed. M., J.D. over thirty years of extensive experience in food and drug law and related subjects such as vaccines, dietary supplements, opioids, tobacco and vaping.

This new 2022 edition features a full print, a full e-book that mirrors the print and 12 subject specific e-books. As a sought out and featured speaker, Ms. Termini frequently presents specialized food and drug law topics. Further, she has published a broad array of timely food, drug and related law issues such as the COVID-19 pandemic, opioid epidemic, medical device safety, vaping and e-cigarettes, federal right-to-try law, dietary supplements, corporate accountability, criminal liability, enforcement, health claims, product classification, personal care products, duty to warn, preemption, drug promotion, stem cells, risk assessment and globalization. She was the first awardee of the Plain English Award. Expertise entails an appellate clerkship, sole corporate counsel, regulatory attorney, and senior deputy attorney general. Ms. Termini initiated the inaugural online food and drug law courses at Widener University, Delaware School of Law and direct-to-consumer promotion at St.

Joseph's University executive degree program. Other expertise includes Johns Hopkins, the University of Georgia, Drexel and Temple Universities and Dickinson Law School. Besides her professional association committee appointments including Vice Chair of Health Law and Legal Services for Disabilities, Board member of the St. Thomas More Law Society, she served on the President's Council at Immaculata University; served as Vice Chancellor Justinian Society, was Chair of a Food and Drug Law Institute Committee and is a member of the Central Atlantic Association of Food and Drug Law Officials. In 2018, Ms. Termini was admitted to the Bar of the United States Supreme Court.